Mdxhealth Announces Resignation of Board Member
February 16 2024 - 8:45AM
Mdxhealth Announces Resignation of Board
Member
IRVINE, CA, and HERSTAL,
BELGIUM – February 16, 2024 (GlobeNewswire) – MDxHealth SA
(NASDAQ: MDXH) (the "Company" or "mdxhealth"), a commercial-stage
precision diagnostics company, today announced that Jan Pensaert
has stepped down from the Board of Directors of mdxhealth. His
resignation was effective as of February 15, 2024. Mr.
Pensaert’s resignation is not the result of any disagreement with
the Company on any matter relating to the operations, policies or
practices of the Company.
Michael K. McGarrity, CEO of mdxhealth,
commented: “On behalf of the Board of Directors and the
employees of mdxhealth, I would like to thank Jan for his support
of our Company. Jan provided valuable insights during a period of
significant transformation for mdxhealth, and we are grateful for
his contributions.”
About mdxhealthMdxhealth is a
commercial-stage precision diagnostics company that provides
actionable molecular information to personalize patient diagnosis
and treatment. The Company’s tests are based on proprietary
genomic, epigenetic (methylation) and other molecular technologies
and assist physicians with the diagnosis and prognosis of urologic
cancers and other urologic diseases. For more information, visit
mdxhealth.com and follow us on social media at:
twitter.com/mdxhealth, facebook.com/mdxhealth and
linkedin.com/company/mdxhealth.
For more information:
info@mdxhealth.com
LifeSci Advisors (IR & PR)US: +1 949 271
9223
ir@mdxhealth.com
MDxHealth (EU:MDXH)
Historical Stock Chart
From May 2024 to Jun 2024
MDxHealth (EU:MDXH)
Historical Stock Chart
From Jun 2023 to Jun 2024